AM KEC International Ltd.(up 5.91%), GE Vernova T&D India Ltd.(up 5.63%), KKV Agro Powers Ltd.(up 5.00%), Power and I ...

Brainbees Solutions Ltd. released its fourth quarter results, showing a mixed performance with notable increases in revenue, ...

Power shares closed higher in the Friday's session. Reliance Power Ltd.(up 16.40%), Gujarat Industries Power Company Ltd.(up 5.90%), Jyoti Structures Ltd.(up 4.70%), Jaiprakash Power Ventures Ltd.(up ...

The Train Control Upgrade Project will design and install a new CBTC system for Muni Metro trains throughout San Francisco’s ...

Hitachi Vantara, a subsidiary of Japanese multinational conglomerate Hitachi, was forced to take servers offline over the weekend to contain an Akira ransomware attack. The company provides data ...

In the last three months, 10 analysts have published ratings on PTC PTC, offering a diverse range of perspectives from bullish to bearish. The following table encapsulates their recent ratings ...

In this storage supplier profile, we look at Hitachi Vantara, which is a small part of a very big organisation. Since we last looked at Hitachi Vantara, its storage portfolio has undergone ...

For the December quarter of FY25, PTC reported a consolidated net profit of ₹181.11 crore—nearly double the ₹97.04 crore posted in the same period the previous year. (Image: Pixabay ...

The Class 385 trains were produced at Hitachi Rail’s County Durham facility. Credit: Hitachi Rail. ScotRail has announced a seven-year extension of its maintenance contract with Hitachi for the Class ...

Engineering and design software provider PTC (NASDAQ:PTC) will be reporting earnings tomorrow afternoon. Here’s what to expect. PTC beat analysts’ revenue expectations by 1% last quarter ...

India’s largest hydropower generator NHPC Ltd is keen on buying out its public sector co-promoters in power trading firm PTC India Ltd, three people aware of the plan said. The Union power ...

PTC Therapeutics’ amyotrophic lateral sclerosis (ALS) prospect has flunked a phase 2 trial, prompting the biotech to drop plans for further development of the drug candidate. The study ...